Lilly (Eli) (LLY)

Accumulated OCI

-$2.76B

Quarterly · Period ending: · USD

LLY logo

LLY Accumulated OCI

Latest reported-$2.76B
LLY Quarterly Accumulated OCI ($0.00 → -$2.76B)
High-resolution chart · PNG

LLY accumulated oci history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lilly (Eli) Accumulated OCI — Quarterly (USD)
Period endingAccumulated OCI (USD)
-2,761,000,000
-2,833,000,000
-2,880,000,000
-3,206,300,000
-3,716,000,000
-3,774,600,000
-4,321,900,000
-4,274,800,000
-4,378,500,000
-4,299,500,000
-4,327,000,000
-3,784,900,000
-3,788,700,000
-3,777,300,000
-3,844,600,000
-4,295,800,000
-4,287,700,000
-4,225,300,000
-4,343,100,000
-6,172,700,000
-6,287,100,000
-6,395,600,000
-6,496,400,000
-6,555,100,000
-6,682,900,000
-6,885,900,000
-6,523,600,000
-5,734,500,000
-5,600,500,000
-5,687,500,000
-8,742,400,000
-5,439,500,000
-6,108,700,000
-5,437,500,000
-5,718,600,000
-4,609,400,000
-4,774,900,000
-5,064,300,000
-5,274,000,000
-4,257,700,000
-4,371,200,000
-4,264,700,000
-4,580,700,000
-4,667,000,000
-4,403,200,000
-4,657,500,000
-3,991,800,000
-2,551,600,000
-1,935,300,000
-1,957,300,000
-2,002,700,000
-3,564,100,000
-3,948,700,000
-4,014,400,000
-3,797,100,000
-3,535,900,000
-3,934,200,000
-3,549,200,000
-3,858,600,000
-2,505,400,000
-2,009,900,000
-2,188,800,000
-2,670,100,000
-2,529,800,000
-3,307,600,000
-2,776,900,000
-2,471,900,000
-2,175,400,000
-2,466,800,000
-3,130,300,000
-5,508,100,000
-3,119,700,000
-2,511,900,000
-2,523,300,000
-2,717,000,000
-3,499,600,000
-3,875,200,000
-4,091,500,000
-4,124,400,000
-2,725,100,000
-2,858,700,000
-3,030,400,000
-3,161,900,000
-2,993,200,000
-3,042,700,000
-2,698,000,000
-2,528,300,000
-2,914,600,000
-2,927,800,000
-2,937,200,000
-2,913,700,000
-3,160,700,000
-3,197,000,000
-3,362,900,000
-3,429,100,000
-3,534,600,000
-3,391,400,000
-3,557,700,000
-3,512,500,000
-3,424,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.